Pulmonary vascular resistance drops sharply within a few minutes after birth for the survival of neonates. A majority of this resistance is caused by "pulmonary vascular bed" or vessel lacking smooth muscle cells. Heparin is known to promote proliferation and development of endothelial cells and to subsequently decrease their overall vascular resistance, but its detailed features remained unknown. Therefore, in this study we treated neonatal rabbits with heparin, protamine (antagonist of heparin), or saline, and evaluated histopathological features of vascular endothelial cells using two different types of computer assisted image analysis, i.e., CAS200 and NIH image. These two systems detected the percentage of vascular endothelial area per fields (VA) and CD31-positive area per total area of tissue following subtraction of background stain. CD31 was used as an endothelial cell marker. Heparin treated rabbits were associated with significant decrement of pulmonary/systemic artery pressure (Pp/Ps) (21.0 ± 6.0%) compared to protamine (29.9 ± 6.1%) or saline (29.4 ± 3.0%) treated animals. The values of VA obtained by the two image analyses (CAS200 and NIH image) were significantly increased in heparin treated animals (38.4 ± 3.2% determined by CAS200 and 24.0 ± 1.3% by NIH image) compared to protamine (30.2 ± 3.9% and 19.2 ± 1.8%) or saline (33.2 ± 1.5% and 20.8 ± 3.8%) treated animals on 14th day of treatment. The present study indicates that heparin accelerates pulmonary vascular bed development probably by increasing the number and volume of endothelial cells, which subsequently contributes to the decrease in pulmonary vascular resistance. pulmonary artery vascular resistance; pulmonary vascular density; heparin; CD31; image analysis
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In congenital heart disease, refined surgical techniques made intracardiac repair or definitive palliation possible for virtually all the patients at this juncture (Juaneda et al. 1985; Pearl et al. 1992) . However, it is also true that ultimate postoperative clinical outcome of some of these patients still remains dismal. Pulmonary vasculature development of these patients is usually insufficient or inadequate during neonatal period due to their immature pulmonary function. Clinically these intrapulmonary vascular development abnormalities usually manifest as elevation of pul-monary vascular resistance but its definitive treatments are still not available (Geggal et al. 1990; Starnes et al. 2000) . Therefore, cardiac surgery in these patients still remains difficult despite recent technical advances.
Angiogenesis, the formation of new blood vessels, has been known to occur in a wide range of both physiological and pathological processes. Especially, angiogenesis plays very important roles in the development of pulmonary circulation (Hall and Haworth 1986) . Intrauterine development of intrapulmonary vascular system and its patency of their lumen at birth through the process of angiogenesis plays pivotal roles in pulmonary function by decreasing intrapulmonary vascular resistance (Haworth and Hislop 1983; Meyrick and Reid 1983) . Pulmonary vascular resistance drops sharply within a few minutes at birth and continues to fall throughout the neonatal period so that neonates can breathe air spontaneously. Its corresponding morphological changes associated with intrapulmonary vascular development include an increment of external diameter and a development of its wall thickness of pulmonary arteries within hours of birth (Haworth and Hislop 1983; Meyrick and Reid 1983) . However, recent studies also demonstrated that a great majority of total pulmonary vascular resistance is associated with the status of development of nonmuscular vessels in vascular bed rather than that of pulmonary small muscular arteries (Haworth and Hislop 1983; Hall and Haworth 1986; Robert et al. 1998) . Therefore, it becomes very important to examine the status of these vessels of "pulmonary vascular bed" in detail in order to obtain a better understanding of development of total pulmonary vascular resistance.
Heparin has been used as a major anticoagulant of cardiac surgery (Robert et al. 1997 ). In addition, heparin is also well-known to exert proliferative effects on vascular endothelial cells and at the same time anti-proliferative effects on vascular smooth muscle cells (SMC) (Gupta and Singh 1994; Han et al. 1997) . Protamine sulfate demonstrated antagonistic effects toward anticoagulant activity of heparin and is commonly employed to reverse the large heparin dosage usually required in cardiovascular surgical procedures (Taylor and Folkman 1982; Pearson et al. 1992 ). Therefore heparin is considered to accelerate intrapulmonary angiogenesis such as pulmonary vascular endothelial cells migration and pulmonary vascular bed development in neonatal period (Han et al. 1997) , which subsequently results in reduction of pulmonary vascular resistance required for the survival of neonates as discussed above. In some institutions, heparin has been clinically employed for this purpose and its clinical efficacy in accelerating development of pulmonary vasculature has been reported (Garg et al. 2000) . However its detailed features including histopathological changes of intrapulmonary vessels associated with heparin treatment has not been examined at all. Therefore, in this study, we examined effects of heparin and its antagonist protamine on development of intrapulmonary vessels, especially those in pulmonary vascular bed through analysis of their development by immunohistochemistry of CD31, a well-characterized endothelial marker in a semi-quantitative manner employing computer assisted image analysis in neonatal rabbit lungs.
MATERIALS AND METHODS

Animal and laboratory
All procedures in this study are in accordance with guide for the Care and Use of Laboratory Animals as adopted by the National Institutes of Health and Helsinki Declaration. The study was approved by the Animal Care Committee of the Tohoku University School of Medicine.
Newborn New Zealand white rabbits weighing between 60 and 120 g were classified into the following three groups at 3 days of age: i) heparin-treated group, ii) protamine-treated group and iii) saline-treated group. Rabbits in the heparin treated group (n = 12) were injected with 450 U/kg/day of heparin sodium (Novo-heparin injection1000, Aventis Pharma Japan, Tokyo) subcutaneously every 12 hours for 14 days. Rabbits in the protamine treated group (n = 12) were administered with 60 mg/kg/day protamine sulfate (Aventis Pharma Japan), in the same manner as above every 12 hours. Rabbits in the control group (n = 12) were also injected with physiological saline (0.45 ml/kg/day) every 12 hours in the same manner as above. In our preliminary study, heparin in-jection of 450 U/kg/day significantly reduced mean pulmonary artery pressure lower (6.9 ± 0.3 mmHg) than the doses of 300 U/kg/day (8.8 ± 0.6 mmHg) or 600 U/kg/ day (10.1 ± 0.5 mmHg). Therefore we employed dosage of 450 U/kg/day in our present study.
Procedures and pressure study
Rabbits were anesthetized with ketamine (80 mg/kg intramuscularly) on 7th day (n = 4 at each groups) and 14th day of treatment (n = 8 at each groups). A polyethylene catheter of 0.023 inch inner diameter (PE50, Becton Dickinson Inc., Sparks, MD, USA) was inserted into the right jugular vein and advanced into the right ventricle. In addition, 24G catheter (SR-OT2419C, Terumo Inc., Tokyo) was inserted into right carotid artery under local anesthesia (1.0 ml of 1% xylocaine, subcutaneously) with spontaneous breathing. These animals were sacrificed with an overdose of pentobarbital (100 mg/kg IV) after measurement of right ventricular pressure and carotid artery pressure. Both lungs were removed immediately after sacrifice. Resected lungs were fixed in the distended state by infusing of 10% phosphate-buffer formalin into the bronchus at 30 cm H 2 O pressure for 20 to 25 min and were subsequently fixed at 4°C for 24 hour. Tissue sections for histopathological and immunohistochemical studies were obtained from lower lobes of these lungs and processed for paraffin embedding.
Immunohistochemical study
Tissue sections of 4 µm thickness were sectioned and placed on TES coated glass slides (Matsunami Co. Ltd., Osaka). The antibody against CD31 was a mouse monoclonal IgG antibody (DACO, Copenhagen, Denmark) and its characteristics have been previously reported . The slides were treated with 1% H 2 O 2 in methanol for 30 min at room temperature, following deparaffinization and hydration rinsed in phosphate-buffered saline (PBS), and then digested with Protenase K (DACO) for 20 min at 4°C. Immunostaining was performed employing a streptavidin-biotin amplified method with alkaline-phosphatase-conjugated streptavidin using Envision ALP (DACO), and the antigen-antibody complex was visualized by CAS Red Cromogen Solution (Becton Dickinson, Lincoln Park, NJ, USA) with 1mM Levamisole (DACO). Methyl Green was used for the counterstaining. For NIH analysis, immunostaining was performed by streptavidin-biotin amplified method with peroxidase-conjugated streptavidin using the Envision HRP (DACO). The antigen-antibody complex was visualized with 3,3´-diaminobenzidine (DAB) solution (1 mM DAB, 50 mM Tris-HCl buffer (pH 7.6), and 0.006% H 2 O 2 ) Methyl Green was used for counterstaining of immunohistochemistry. Negative control for immunostaining was performed in the same manner as above without the antibody against CD31. No specific immunoreactivity was detected.
Computer assisted image analysis of CD31 immunoreactivity
Detail of the CAS200 computer image analysis system (Becton Dickinson) were reported previously (Kallakury et al. 1996; Sasano et al. 1998 ). The newly developed imaging program, Quantitative Angiogenesis software were integral parts of CAS200 system (version 1.0.03), which worked at both 20x and 40x magnification. This program has been used for semi-quantitative morphological evaluation of the CD31 positive cells Tetlow et al. 1999 ). Immunoreactivity was identified with CAS Red, and counterstained with Methyl Green. This combination of CAS Red and Methyl Green matched the CAS200 optical coupler. The CAS Red could be evaluated by the 500-nm charge-coupled device (CCD) camera and the Methyl Green by the 620-nm CCD camera. The software evaluated the percentage of vascular endothelial area per fields (VA) by calculating CD31-positive area per total area of tissue excluding background area. Detailed procedures of an application of this program in evaluating vascularity in histological sections were discussed previous Suzuki et al. 1998; Tetlow et al. 1999) .
Another quantitative analysis of evaluating vascular density which we employed in our present study, was the free public domain NIH image software (version 1.61, developed at the U.S. National Institute of Health and available on the internet at http://rsb.info.nih.gov/nihimage/download.html). In NIH image software, RGB images were acquired in a Macintosh computer using a RD-175 digital camera for light microscopy and Adobe Photoshop (Adobe Systems, Mountain View, CA, USA) program, followed by conversion of the RGB image to G (green subtracted) images. We employed the "Cell counting macro" for automatic detection, threshold-setting, and generation of a binary image of the CD31. We used "Computer percent black and white" command in the "Measurement macros" to automatically determine the CD31 density (%), which was subsequently repre-sented as percentage of the total area of CD31 immunopositive area by per observation area. An application of the NIH image analysis methods for evaluation of vascularity has been reported previously (Zhang et al. 2000) . Briefly, images of the immunostained slides on 40X magnification were captured by RD-175 digital camera and manipulated 8-bit gray scale with TIFF file format following conversion of the RGB image to green subtracted images by Adobe Photoshop software. We started NIH image, and then "Cell counting macro" was loaded under the "Special" menu and the submenu "Load macros" within the macro was selected. In NIH image the "Cell counting macro" was obtained from the NIH image web site (fttp://rsbweb.nih.gov/pub/nih-image/user-macros). However this "Cell counting macro" was not suitable unless some modifications were made. We mainly modified the parameter of background setting and auto detected system in our present study. Our modification of "Cell counting macro" for vascularity in immunohistochemistry of CD31 is available on request (e-mail: sug uruw@mail.tains.tohoku.ac.jp).
Each slide was magnified at 40x objective. We studied 40 images which excluded major vessels and bronchioles. In both of these analyses, the areas for evaluation were determined by simultaneous examination of all immunostained slides by two of the authors (SW and TS) using a double headed light microscopy.
Statistical analysis
Student's t-test was applied to evaluate differences in each value among the heparin-treated group, the saline-treated group and protamine treated groups. All values were expressed as the mean ± standard error of the mean (S.E.M.). The Student's t-test was used; p < 0.05 was considered to be statistically significant.
RESULTS
Evaluation of Arterial Pressure in neonatal rabbits
Results are summarized in Table 1 . In this study, pulmonary artery pressure was evaluated as right ventricular systolic pressure. On the 7th day of treatment, pulmonary artery pressure in saline treated group decreased to the level compatible with heparin and protamine treated groups. However there were no significant differences in pulmonary/systemic artery pressure (Pp/Ps) among each group examined. On the 14th day of treatment, heparin-treated group demonstrated significant decrement in Pp/Ps (21.0 ± 4.0%) compared to saline-treated group (29.4 ± 3.0%) and protamine-treated group (30.0 ± 4.4%) (Table1).
Analysis of intrapulmonary vessels through CD31 immunohistochemistry using computer assisted image analysis
Representative microscopic findings of CD31 immunostaining were illustrated in Fig. 1 . On the seventh day of treatment, systemic artery pressure and pulmonary artery pressure in saline treated group decreased to the level compatible with heparin and protamine treated groups. However there were no significant differences. * p < 0.006 and ** p < 0.005 compared with the values of heparin-treated animals on 14th day. CD31 immunoreactivity was identified as brown as a result of DAB colorimetric action. Negative control of immunostaining was also illustrated in Fig. 1 . Table 2 demonstrated results of the computer assisted image analysis of CD31 immunoreactivity. We used the two different types of image analysis CAS200 and NIH image in order to confirm the findings. Both methods have been w i d e l y e m p l o y e d f o r i m a g e a n a l y s i s o f immunohistochemical findings Suzuki et al. 1998; Amin et al. 2000; Zhang et al. 2000) . There were no significant differences in VA at 7th day of treatment among heparin (33.4 ± 3.3%), protamine (33.6 ± 1.9%) and saline (33.8 ± 0.3%) treated groups, measured by CAS200. On the 14th day of treatment, heparin-treated group (38.4 ± 3.2%) demonstrated significantly higher vascular areas than protamine (30.2 ± 3.9%) and saline (33.2 ± 1.5%) treated groups. Analysis using NIH image program yielded results similar to those of CAS200 above both on the 7th day (heparin, 20.6 ± 1.4%, protamine, 20.1 ± 1.6%, saline, 22.2 ± 1.0%) and the 14th day (heparin, 24.0 ± 1.3%, protamine, 19.2 ± 1.8%, saline, 20.8 ± 3.8%) ( Table 3 ). Significant increment of vascular density was detected in the group treated with heparin for 14th day of treatment using NIH image program.
DISCUSSION
Heparin is a well-established anticoagulation compound employed in open heart surgery and cardiac catheterization (Robert et al. 1997) . Clinically heparin has been used in the patients associated with congenital heart disorders because development of pulmonary vascular bed is mandatory prior to open-heart surgery in order to achieve successful clinical outcome (Geggal et al. 1990; Starnes et al. 2000 Starnes et al. , 2001 . Heparin administration to these patients above induce vascular proliferation, which could contribute to cordial operation. Heparin is also considered to be involved in the regulation of neonatal pulmonary artery development chiefly through its ability to promote angiogenesis in conjunction with various growth factors (Leopald et al. 1998; Starnes et al. 2001 ). However it is also true that its angiogenesis-promoting effects were not necessarily well characterized. Azizkhan et al. (1980) first reported that heparin induced expression of angiogenic substances in mast cells. Hoover et al. (1980) subsequently demonstrated that heparin stimulated the growth of bovine aortic endothelial cells in vitro, but heparin was also demonstrated to inhibit the proliferation of fibroblasts and SMC. Potential biological roles of heparin in the process of angiogenesis has been mainly examined in relation to other growth factors, such as acidic fibroblast growth factor (aFGF) (Mueller et al. 1989; Jesundason et al. 2000) , basic fibroblast growth factor (bFGF) (Yamashita et al. 1992; Toriyama et al. 1997 ) and vascular endothelial growth factor (VEGF) (Heaky et al. 2000; Norrby 2000) . Heparin is also known to stimulate the proliferation of vascular endothelial cells (Yamashita et al. 1992) , which results in enhancement of pulmonary maturation process through increased vascular density. Protamine is one of the family of basic, arginine-rich proteins in which reversal of heparin anticoagulation occasionally results in pulmonary hypertension as well as systemic hypotension (Pearson et al. 1992; Friedman et al. 1994; Han et al. 1997; Murase et al. 2001) . Therefore, protamine has been also employed as an antagonist of heparin in various clinical settings.
In our present study, we first demonstrated that heparin decreased pulmonary artery resistance obtained as right ventricular pressure in neonate rabbits while protamine, its antagonist, increased. These results also suggest that heparin may decrease vascular resistance possibly through promoting pulmonary vascular proliferation. Heparin has been demonstrated to promote vascular cells proliferation and to enhance effects of various growth factors involved in the process of vascular growth as described above (Mueller et al. 1989; Yamashita et al. 1992; Toriyama et al. 1997; Heaky et al. 2000; Jesundason et al. 2000; Norrby 2000) . The potential contact between heparin and its cell surface receptor is considered a critical and initial step in these antiproliferative effects of heparin (Gupta et al. 1994; Han et al. 1997) . In addition pharmacological effects of heparin have been considered mainly anticoagulant effects and angiogenesis through interactions with a family of polypeptide growth factor that stimulated endothelial cell proliferation (Garg et al. 2000) . Results of various studies demonstrated that angiogenesis by heparin may be regulated by nitric oxide (NO) and high dose heparin injection resulted in systemic hypotension by NO synthesis (Casthely et al. 1990; Pu et al. 2002; Prior et al. 2003) . In addition Upchurch et al. (1997) reported high dose heparin decreased NO production. In our present study we injected heparin subcutaneously, which is considered to exert relatively long term effects on neonatal rabbits. However, further investigations are required for clarification of its mechanism.
Pulmonary vascular resistance is generally evaluated under positive pressure ventilation with insertion of the ventilator tube. However, blood flow of capillaries and vascular bed are not associated with vascular smooth muscle in their wall, and have been also well-known to be markedly affected by this procedure (Fisher et al. 1998; Robert et al. 1998; Miserocchi et al. 2001) . Therefore, results of the experiments employing this procedure were not necessarily physiologically and/or pathophysiologically relevant and a great care should be taken for an interpretation of the results (Fisher et al. 1998) . Therefore in our present study, we preformed an experiment under spontaneous respiration in order to avoid potentially detrimental effects on interpretation of the results by positive pressure ventilation discussed above. Haworth and Hislop (1983) examined development of normal pulmonary vascular structure. They reported that a reduction of arterial smooth-muscle was associated with decrement of Pp/Ps. An increment of the number of pulmonary arteries is also considered to contribute to the progressive reduction in pulmonary vascular resistance normally seen during infancy (Haworth and H i s l o p 1 9 8 3 ; M e y r i c k a n d R e i d 1 9 8 3 ) . Pulmonary artery resistance is caused by both pulmonary arteries with SMC and pulmonary vessels without SMC or pulmonary vascular bed (Hall and Haworth 1986; Robert et al. 1998 ). However progressive reduction in pulmonary vascular resistance following birth is generally associated with histological changes within the pulmonary vascular bed, not those within pulmonary artery with SMC as discussed above (Hall and Haworth 1986) . Robert et al. (1998) reported that no more than 50% of the total resistance is associated with vessels of less than 40 micron in their diameter. Therefore, it becomes very important to study the status and/or development of pulmonary vascular bed in detail in order to understand pathophysiology of pulmonary vascular resistance. It is, however, also true that a detailed evaluation of these vessels in pulmonary vascular bed can be very difficult due to their ill defined structures compared to pulmonary vessels with SMC (Fisher et al. 1998; Robert et al. 1998; Miserocchi et al. 2001) . Therefore, computer assisted image analysis of vascular endothelial marker can provide very important information as to obtain a better understanding of these intrapulmonary vascular structure.
CD31 antibody reacts specifically to the vascular endothelium in rabbits and other animals (Zhang et al. 2000) . Therefore immunohistochemistry using CD31 antibody could detect almost all endothelial cells, with less background staining than Factor VIII, the other immunohistochemical marker of endothelium frequently used for morphological evaluation (Zhang et al. 2000) . Therefore, we employed CD31 immunohistochemistry in order to evaluate the status of pulmonary vascular bed in this study. Pulmonary vascular bed contains both pulmonary arteries of less than 100µm and vein (Robert et al. 1998 ). These vessels usually consisted of a single endothelial lining and elastic lamina without a muscular media. It is therefore difficult to distinguish the pulmonary capillaries as separate structures within the thin alveolar walls. CD31 antibody recognized vascular endothelium of both arteries and veins. When analyzing the status of intrapulmonary vasculature, areas of endothelial cells per lung tissues regardless of patency of their lumen are considered to represent the status of potential development of intrapulmonary circulation because an increment of endothelial cells is considered mandatory and/or prerequisite for decreasing intrapulmonary vascular resistance (Maeda et al. 2002) . Therefore, CD31 immunohistochemistry and subsequent evaluation of its findings using computer assisted image analysis are considered an appropriate marker in evaluation of pulmonary vascular bed. In addition, CD31 immunohistochemistry can provide important information as to localization of the findings, which makes correlation of the findings with morphological features possible. This feature of an analysis is very important when studying expression of molecules in a structure whose features change in both temporal and spatial manners including neonatal lungs. CAS200 Suzuki et al. 1998 ) and NIH image (Amin et al. 2000; Zhang et al. 2000) have been widely used as computer assisted image analysis of immunohistochemical findings especially in a quantitative or semi-quan-titative analysis of endothelial cells through evaluating immunoreactivity of various endothelial markers (Zhang et al. 2000; Salvato 2001 ). In our present study heparin increased and protamine decreased vessel area evaluated by both methods of image analysis. Results of these two methods of image analysis also suggest that heparin may work as one for growth factors involved in vascular endothelial proliferation as reported in other tissues (Han et al. 1997; Toriyama et al. 1997; Jesundason et al. 2000; Pinhal et al. 2001) , although further investigations are required for confirmation.
